N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MCDANIEL, STACEY LEIGH KOENIG, THOMAS MITCHELL BUCCILLI, LYNNE ANN ENGEL, GARY LOWELL AIKINS, JAMES ABRAHAM MITCHELL, DAVID AUDIA, JAMES EDMUND |
| description | The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2425497C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2425497C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2425497C3</originalsourceid><addsrcrecordid>eNqFjb1qw0AQhNWkCE6eIdtFBm2hHxNcrqU1d3Bahbs15NQYEy6VsQ32a-UdcwmBlKmm-L6ZuS8-ZYllGZbYoImDn94itjiymuhws9Poc9ZYOiRHYiW6rGe7RhqtTH9uU7VVV61QWT39LGFtMt6wzDTzq5X8MAnDYL8pKQPJAFYD7AKDFVDDoJ5JRxaFaQvkZsN2ZP8cciswBX4o7j4Ox2t6_M1F8bRl7Q2my3mfrpfDezql276npmtW3fqlb_83vgAn90VF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE</title><source>esp@cenet</source><creator>MCDANIEL, STACEY LEIGH ; KOENIG, THOMAS MITCHELL ; BUCCILLI, LYNNE ANN ; ENGEL, GARY LOWELL ; AIKINS, JAMES ABRAHAM ; MITCHELL, DAVID ; AUDIA, JAMES EDMUND</creator><creatorcontrib>MCDANIEL, STACEY LEIGH ; KOENIG, THOMAS MITCHELL ; BUCCILLI, LYNNE ANN ; ENGEL, GARY LOWELL ; AIKINS, JAMES ABRAHAM ; MITCHELL, DAVID ; AUDIA, JAMES EDMUND</creatorcontrib><description>The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100817&DB=EPODOC&CC=CA&NR=2425497C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100817&DB=EPODOC&CC=CA&NR=2425497C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCDANIEL, STACEY LEIGH</creatorcontrib><creatorcontrib>KOENIG, THOMAS MITCHELL</creatorcontrib><creatorcontrib>BUCCILLI, LYNNE ANN</creatorcontrib><creatorcontrib>ENGEL, GARY LOWELL</creatorcontrib><creatorcontrib>AIKINS, JAMES ABRAHAM</creatorcontrib><creatorcontrib>MITCHELL, DAVID</creatorcontrib><creatorcontrib>AUDIA, JAMES EDMUND</creatorcontrib><title>N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE</title><description>The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjb1qw0AQhNWkCE6eIdtFBm2hHxNcrqU1d3Bahbs15NQYEy6VsQ32a-UdcwmBlKmm-L6ZuS8-ZYllGZbYoImDn94itjiymuhws9Poc9ZYOiRHYiW6rGe7RhqtTH9uU7VVV61QWT39LGFtMt6wzDTzq5X8MAnDYL8pKQPJAFYD7AKDFVDDoJ5JRxaFaQvkZsN2ZP8cciswBX4o7j4Ox2t6_M1F8bRl7Q2my3mfrpfDezql276npmtW3fqlb_83vgAn90VF</recordid><startdate>20100817</startdate><enddate>20100817</enddate><creator>MCDANIEL, STACEY LEIGH</creator><creator>KOENIG, THOMAS MITCHELL</creator><creator>BUCCILLI, LYNNE ANN</creator><creator>ENGEL, GARY LOWELL</creator><creator>AIKINS, JAMES ABRAHAM</creator><creator>MITCHELL, DAVID</creator><creator>AUDIA, JAMES EDMUND</creator><scope>EVB</scope></search><sort><creationdate>20100817</creationdate><title>N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE</title><author>MCDANIEL, STACEY LEIGH ; KOENIG, THOMAS MITCHELL ; BUCCILLI, LYNNE ANN ; ENGEL, GARY LOWELL ; AIKINS, JAMES ABRAHAM ; MITCHELL, DAVID ; AUDIA, JAMES EDMUND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2425497C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCDANIEL, STACEY LEIGH</creatorcontrib><creatorcontrib>KOENIG, THOMAS MITCHELL</creatorcontrib><creatorcontrib>BUCCILLI, LYNNE ANN</creatorcontrib><creatorcontrib>ENGEL, GARY LOWELL</creatorcontrib><creatorcontrib>AIKINS, JAMES ABRAHAM</creatorcontrib><creatorcontrib>MITCHELL, DAVID</creatorcontrib><creatorcontrib>AUDIA, JAMES EDMUND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCDANIEL, STACEY LEIGH</au><au>KOENIG, THOMAS MITCHELL</au><au>BUCCILLI, LYNNE ANN</au><au>ENGEL, GARY LOWELL</au><au>AIKINS, JAMES ABRAHAM</au><au>MITCHELL, DAVID</au><au>AUDIA, JAMES EDMUND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE</title><date>2010-08-17</date><risdate>2010</risdate><abstract>The present invention provides crystalline (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one dihydrate, compositions thereof, and methods for using the same, processes for making the same, and processes for making intermediates thereof.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2425497C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | N)-((S)-2-HYDROXY-3-METHYL-BUTYRYL-1-(L-ALANINYL)-(S)-1-AMINO-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-2-ONE DIHYDRATE AND ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A19%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCDANIEL,%20STACEY%20LEIGH&rft.date=2010-08-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2425497C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |